Aveanna Healthcare (AVAH) Expected to Announce Quarterly Earnings on Thursday

Aveanna Healthcare (NASDAQ:AVAH) is expected to be posting its Q1 2026 results before the market opens on Thursday, May 14th. Analysts expect Aveanna Healthcare to post earnings of $0.13 per share and revenue of $613.2190 million for the quarter. Individuals are encouraged to explore the company’s upcoming Q1 2026 earning overview page for the latest details on the call scheduled for Thursday, May 14, 2026 at 10:00 AM ET.

Aveanna Healthcare Stock Performance

NASDAQ:AVAH opened at $6.76 on Thursday. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 6.62. Aveanna Healthcare has a fifty-two week low of $3.73 and a fifty-two week high of $10.32. The stock has a market cap of $1.47 billion, a PE ratio of 6.63 and a beta of 1.93. The firm’s fifty day simple moving average is $6.75 and its 200-day simple moving average is $8.04.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on the stock. Truist Financial lowered their price target on shares of Aveanna Healthcare from $9.00 to $8.00 and set a “hold” rating on the stock in a research note on Monday, April 13th. Weiss Ratings cut shares of Aveanna Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday, April 6th. UBS Group upped their price target on shares of Aveanna Healthcare from $9.50 to $10.00 and gave the stock a “neutral” rating in a research note on Thursday, January 15th. Raymond James Financial raised shares of Aveanna Healthcare from an “outperform” rating to a “strong-buy” rating and set a $13.00 price target on the stock in a research note on Friday, March 20th. Finally, Barclays lowered their price objective on shares of Aveanna Healthcare from $11.00 to $9.50 and set an “overweight” rating on the stock in a research note on Wednesday, March 25th. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and six have given a Hold rating to the company. According to MarketBeat, Aveanna Healthcare has an average rating of “Moderate Buy” and a consensus price target of $10.25.

Insider Transactions at Aveanna Healthcare

In related news, CEO Jeff Shaner sold 173,225 shares of the stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $7.21, for a total value of $1,248,952.25. Following the sale, the chief executive officer directly owned 2,650,892 shares of the company’s stock, valued at approximately $19,112,931.32. This represents a 6.13% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Matthew Buckhalter sold 13,512 shares of the stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $7.21, for a total transaction of $97,421.52. Following the completion of the sale, the chief financial officer directly owned 529,243 shares in the company, valued at approximately $3,815,842.03. The trade was a 2.49% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 738,957 shares of company stock worth $5,458,175 in the last 90 days. Insiders own 5.30% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Police & Firemen s Retirement System of New Jersey lifted its holdings in Aveanna Healthcare by 37.9% in the 4th quarter. Police & Firemen s Retirement System of New Jersey now owns 17,707 shares of the company’s stock valued at $145,000 after purchasing an additional 4,864 shares in the last quarter. Fox Run Management L.L.C. purchased a new position in Aveanna Healthcare in the 4th quarter valued at about $138,000. Raymond James Financial Inc. lifted its holdings in Aveanna Healthcare by 287.7% in the 3rd quarter. Raymond James Financial Inc. now owns 17,532 shares of the company’s stock valued at $156,000 after purchasing an additional 13,010 shares in the last quarter. Dynamic Technology Lab Private Ltd lifted its holdings in Aveanna Healthcare by 8.9% in the 3rd quarter. Dynamic Technology Lab Private Ltd now owns 14,149 shares of the company’s stock valued at $126,000 after purchasing an additional 1,151 shares in the last quarter. Finally, Sei Investments Co. lifted its holdings in Aveanna Healthcare by 71.1% in the 2nd quarter. Sei Investments Co. now owns 29,271 shares of the company’s stock valued at $153,000 after purchasing an additional 12,160 shares in the last quarter. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.